Cambridge Investment Research Advisors’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ECAT
SCM
PCM
AAM
Cambridge Investment Research Advisors's ECAT Position: Q1 2026 in Review
Cambridge Investment Research Advisors increased its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 34% in Q1 2026, buying an estimated $61.7K and bringing the position to 16,097 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #3593.
Cambridge Investment Research Advisors first reported a position in ECAT in Q3 2023 and has held it in 11 quarters since. The position peaked at $401K in Q2 2025. 84 funds tracked by Wall St. Rank hold ECAT as of Q1 2026.
- Cambridge Investment Research Advisors held 16,097 shares of BlackRock ESG Capital Allocation Term Trust worth $219K as of Q1 2026.
- Cambridge Investment Research Advisors bought 4,118 BlackRock ESG Capital Allocation Term Trust shares in Q1 2026, an estimated $61.7K.
- BlackRock ESG Capital Allocation Term Trust made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #3593 holding.
- Cambridge Investment Research Advisors first reported a position in BlackRock ESG Capital Allocation Term Trust in Q3 2023 and has held it in 11 quarters since.
- Cambridge Investment Research Advisors's BlackRock ESG Capital Allocation Term Trust position peaked at $401K in Q2 2025.
- 84 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q1 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.